Transaction · 0001193125-26-426878

Kulkarni Samarth

Kulkarni Samarth, CEO, reported an open-market or private sale at CRISPR Therapeutics AG involving 47837.000000 shares for an estimated $2381325.86. Reported holdings after the transaction were 311899.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCEO
CRSPCRISPR Therapeutics AG
Trade date
Oct 19, 2026
Filing date
Oct 20, 2026
View on SEC Insider profile
Estimated value-$2.38MShares × reported price
Shares traded47.8k$49.78 per share
Holdings after311kDirect
% of reported position traded13.3%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 359,736 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CRSP price since this filing

Daily closing prices, with the filing date and available return windows
CRSP · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago +3.3%1d ago -1.3%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-426878
Common Shares
Transaction date
Oct 19, 2026
Filed Oct 20, 2026, 09:35 PM · 1d delay
Shares
47,837 sh
$49.78 per share
Estimated value
-$2.38M
Computed from shares × price
Holdings after
311,899 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Sale Repeat Seller
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

  2. F2

    Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This…

  3. F3

    This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares v…

Original filing · 0001193125-26-426878
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CRSP